Financial statements Apteka Panaceum
Balance sheet data of APTEKA PANACEUM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 418 178,38 | 288 386,26 | 257 645,70 | 643 626,93 | 1 066 504,74 | 1 163 847,88 |
| A. Fixed assets | 16 576,10 | 12 782,96 | 5 323,07 | 237 499,99 | 665 942,71 | 792 354,84 |
| B. Current assets | 401 602,28 | 275 603,30 | 252 322,63 | 406 126,94 | 400 562,03 | 371 493,04 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | - | - | - |
| D. Own shares (stocks) | - | - | 0,00 | - | - | - |
| Total liabilities | 418 178,38 | 288 386,26 | 257 645,70 | 643 626,93 | 1 066 504,74 | 1 163 847,88 |
| A. Equity | 148 138,38 | 176 393,79 | 157 872,63 | 252 104,43 | 409 174,59 | 482 160,45 |
| B. Liabilities and provisions for liabilities | 270 040,00 | 111 992,47 | 99 773,07 | 391 522,50 | 657 330,15 | 681 687,43 |
| I. Long-term liabilities | - | - | 0,00 | 254 212,33 | 466 672,33 | 449 960,00 |
| II. Short-term liabilities | - | - | 99 773,07 | 137 310,17 | 190 657,82 | 231 727,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.